Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $58.24 USD
Change Today +1.52 / 2.68%
Volume 2.5M
ISIS On Other Exchanges
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - isis pharmaceuticals inc (ISIS)

NameBoard RelationshipsTitleAge
Stanley T. Crooke M.D., Ph.D.14 RelationshipsFounder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee69
Elizabeth L. Hougen No RelationshipsChief Financial Officer and Senior Vice President of Finance52
B. Lynne Parshall Esq., J.D.47 RelationshipsChief Operating Officer, Corporate Secretary, Director and Member of Agenda Committee60
Kleanthis G. Xanthopoulos Ph.D.137 RelationshipsSenior Vice President, Chief Executive Officer of Regulus Therapeutics Inc and President of Regulus Therapeutics Inc56
Martin P. Bedigian M.D.No RelationshipsChief Medical Officer and Vice President--

Board Members - isis pharmaceuticals inc (ISIS)

NameBoard RelationshipsPrimary CompanyAge
Stanley T. Crooke M.D., Ph.D.14 RelationshipsIsis Pharmaceuticals, Inc.69
B. Lynne Parshall Esq., J.D.47 RelationshipsIsis Pharmaceuticals, Inc.60
Joseph Harris Wender 137 RelationshipsOutfront Media Inc.70
Spencer R. Berthelsen M.D.7 RelationshipsKS Management Services, LLC62
Frederick T. Muto J.D., Esq.7 RelationshipsCooley LLP60

Executive Committees* - isis pharmaceuticals inc (ISIS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeJoseph Harris Wender 137 Relationships3 Executives
Compensation CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
Nominating CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
Corporate Governance CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
View ISIS Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $58.24 USD +1.52

ISIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $35.67 USD +1.50
Acorda Therapeutics Inc $29.77 USD -0.30
Aegerion Pharmaceuticals Inc $23.61 USD +0.35
Depomed Inc $23.86 USD +0.60
Impax Laboratories Inc $46.38 USD +1.12
View Industry Companies

Industry Analysis


Industry Average

Valuation ISIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.2x
Price/Book 26.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 26.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at